Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Huizinga

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Idrugs : the Investigational Drugs Journal|May 10, 2008
NCX-4016 NicOx SAT W Huizinga
Idrugs : the Investigational Drugs Journal|September 15, 2005
Gene Therapy of Arthritis and Related Disorders--First International Meeting. 2-3 December 1998, Bethesda, USAT W Huizinga
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 30, 2000
Low soluble FcRIII receptor demonstrates reduced neutrophil reserves in preterm neonatesR Carr, T W Huizinga
Methods in Molecular Medicine|February 22, 2011
Molecular analysis of gene-polymorphisms affecting the host response to infectionR G Westendorp, T W Huizinga
British Journal of Rheumatology|October 23, 1998
Tumour necrosis factor alpha gene polymorphisms and rheumatic diseasesC L Verweij, T W Huizinga
Springer Seminars in Immunopathology|July 18, 2001
What will treatment of autoimmune diseases entail in 2010?T W Huizinga, F C Breedveld
Clinical and Experimental Rheumatology|March 20, 1999
The accuracy of diagnosing neuropsychiatric systemic lupus erythematosus in a series of 49 hospitalized patientsM J Rood, F C Breedveld, T W Huizinga
The Journal of Rheumatology|March 1, 1996
Regulation of tumor necrosis factor-alpha production: basic aspects and pharmacological modulationT W Huizinga, B M Brinkman, C L Verweij
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Classifying lupus nephritis: a 32-year-old woman with systemic lupus erythematosus and nephritic syndromeJ A Bruijn, C A Verburgh, T W Huizinga
The Journal of Rheumatology|August 24, 2000
Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapyM J Rood, S E Borggreve, T W Huizinga
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Idrugs : the Investigational Drugs Journal|May 10, 2008
NCX-4016 NicOx SAT W Huizinga
Idrugs : the Investigational Drugs Journal|September 15, 2005
Gene Therapy of Arthritis and Related Disorders--First International Meeting. 2-3 December 1998, Bethesda, USAT W Huizinga
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 30, 2000
Low soluble FcRIII receptor demonstrates reduced neutrophil reserves in preterm neonatesR Carr, T W Huizinga
Methods in Molecular Medicine|February 22, 2011
Molecular analysis of gene-polymorphisms affecting the host response to infectionR G Westendorp, T W Huizinga
British Journal of Rheumatology|October 23, 1998
Tumour necrosis factor alpha gene polymorphisms and rheumatic diseasesC L Verweij, T W Huizinga
Springer Seminars in Immunopathology|July 18, 2001
What will treatment of autoimmune diseases entail in 2010?T W Huizinga, F C Breedveld
Clinical and Experimental Rheumatology|March 20, 1999
The accuracy of diagnosing neuropsychiatric systemic lupus erythematosus in a series of 49 hospitalized patientsM J Rood, F C Breedveld, T W Huizinga
The Journal of Rheumatology|March 1, 1996
Regulation of tumor necrosis factor-alpha production: basic aspects and pharmacological modulationT W Huizinga, B M Brinkman, C L Verweij
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Classifying lupus nephritis: a 32-year-old woman with systemic lupus erythematosus and nephritic syndromeJ A Bruijn, C A Verburgh, T W Huizinga
The Journal of Rheumatology|August 24, 2000
Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapyM J Rood, S E Borggreve, T W Huizinga
Pageof 11